Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study of Nimotuzumab in Combination With Concurrent Chemotherapy and Radiation for Patients With Local Advanced Esophageal Squamous Cell Carcinoma

NCT01232374 is registered in ClinicalTrials.gov with Biotech Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT01232374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01232374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study of Nimotuzumab in Combination With Concurrent Chemotherapy and Radiation for Patients With Local Advanced Esophageal Squamous Cell Carcinoma
Lead sponsor
Biotech Pharmaceutical Co., Ltd.
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2010
Completion date
January 31, 2016
Enrollment
144 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell carcinoma